{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:42:55Z","timestamp":1790991775951,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2006]]},"DOI":"10.1016\/j.neuroscience.2006.05.043","type":"journal-article","created":{"date-parts":[[2006,7,4]],"date-time":"2006-07-04T20:27:15Z","timestamp":1152044835000},"page":"1835-1848","source":"Crossref","is-referenced-by-count":64,"title":["Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington\u2019s disease"],"prefix":"10.1016","volume":"141","author":[{"given":"J.K.","family":"Ryu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.B.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"McLarnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2006.05.043_bib1","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1046\/j.1460-9568.2000.00226.x","article-title":"Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain","volume":"12","author":"Acarin","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib2","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1073\/pnas.0500055102","article-title":"Identification of combinatorial drug regimens for treatment of Huntington\u2019s disease using Drosophila","volume":"102","author":"Agrawal","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib3","doi-asserted-by":"crossref","first-page":"14014","DOI":"10.1073\/pnas.93.24.14014","article-title":"A novel mechanism of action of tetracyclines","volume":"93","author":"Amin","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington\u2019s disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib5","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.4049\/jimmunol.162.6.3160","article-title":"Tetracycline up-regulates COX-2 expression and prostaglandin E2 production independent of its effect on nitric oxide","volume":"162","author":"Attur","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2004.09.017","article-title":"Minocycline in phenotypic models of Huntington\u2019s disease","volume":"18","author":"Bantubungi","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrn1386","article-title":"Experimental therapeutics in transgenic mouse models of Huntington\u2019s disease","volume":"5","author":"Beal","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00415-005-0595-4","article-title":"Creatine supplementation lowers brain glutamate levels in Huntington\u2019s disease","volume":"252","author":"Bender","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib9","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1523\/JNEUROSCI.16-04-01324.1996","article-title":"Superoxide production in rat hippocampal neurons","volume":"16","author":"Bindokas","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00004850-200411000-00004","article-title":"Neuroprotection in Huntington\u2019s disease","volume":"19","author":"Bonelli","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/80538","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease","volume":"6","author":"Chen","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib12","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1523\/JNEUROSCI.4306-04.2005","article-title":"Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo","volume":"25","author":"Choi","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2004.10.039","article-title":"Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline","volume":"505","author":"Cornet","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib14","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.1523\/JNEUROSCI.17-23-09060.1997","article-title":"Pyruvate protects neurons against hydrogen peroxide-induced toxicity","volume":"17","author":"Desagher","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib15","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1111\/j.0953-816X.2004.03372.x","article-title":"Deleterious effects of minocycline in animal models of Parkinson\u2019s disease and Huntington\u2019s disease","volume":"19","author":"Diguet","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0006-8993(01)02378-2","article-title":"Time course of glial proliferation and glial apoptosis following excitotoxic CNS injury","volume":"902","author":"Dihne","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib17","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib18","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/sj.jcbfm.9600121","article-title":"Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion","volume":"25","author":"Fox","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jneuroim.2004.09.006","article-title":"Additive effect of the combination of glatiramer acetate and minocycline in a model of MS","volume":"158","author":"Giuliani","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1471-4159.2003.01670.x","article-title":"Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord","volume":"85","author":"Hu","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/WNL.57.3.397","article-title":"A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington\u2019s disease","volume":"57","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/01.WNL.0000133403.30559.FF","article-title":"Minocycline safety and tolerability in Huntington disease","volume":"63","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.brainres.2005.08.029","article-title":"Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain","volume":"1060","author":"Kim","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/sj.jcbfm.9600040","article-title":"Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice","volume":"25","author":"Koistinaho","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib26","doi-asserted-by":"crossref","first-page":"RC171","DOI":"10.1523\/JNEUROSCI.21-20-j0002.2001","article-title":"Protection by pyruvate against transient forebrain ischemia in rats","volume":"21","author":"Lee","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.035048","article-title":"Role of microglia in inflammation-mediated neurodegenerative diseases","volume":"304","author":"Liu","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib28","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ana.20078","article-title":"Prostanoids, not reactive oxygen species, mediate COX-2-dependent neurotoxicity","volume":"55","author":"Manabe","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1750-3639.2000.tb00278.x","article-title":"The role of mitochondria in the pathogenesis of neurodegenerative diseases","volume":"10","author":"Manfredi","year":"2000","journal-title":"Brain Pathol"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib30","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1046\/j.1460-9568.1999.00745.x","article-title":"Pyruvate and lactate protect striatal neurons against N-methyl-d-aspartate-induced neurotoxicity","volume":"11","author":"Maus","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib31","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1460-9568.2005.03895.x","article-title":"A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington\u2019s disease","volume":"21","author":"Morton","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0306-4522(96)00034-6","article-title":"Antioxidant treatment protects striatal neurons against excitotoxic insults","volume":"73","author":"Nakao","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib33","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2005"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib34","first-page":"103","article-title":"Sodium pyruvate infusions in patients with alcoholic liver disease. Preliminary report","volume":"25","author":"Petkova","year":"2000","journal-title":"Acta Physiol Pharmacol Bulg"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.10092","article-title":"Inhibition of autoimmune encephalomyelitis by a tetracycline","volume":"51","author":"Popovic","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib36","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.nbd.2005.04.010","article-title":"Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum","volume":"20","author":"Ryu","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/glia.20051","article-title":"Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus","volume":"48","author":"Ryu","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.expneurol.2004.01.006","article-title":"Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington\u2019s disease","volume":"187","author":"Ryu","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib39","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0014-4886(03)00214-0","article-title":"Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington\u2019s disease","volume":"183","author":"Ryu","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib40","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1097\/00001756-200108280-00020","article-title":"In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum","volume":"12","author":"Santamaria","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1471-4159.2003.01857.x","article-title":"Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats","volume":"86","author":"Santamaria","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbadis.2005.11.002","article-title":"Combination therapy using minocycline and coenzyme Q10 in R6\/2 transgenic Huntington\u2019s disease mice","volume":"1762","author":"Stack","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib43","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington\u2019s disease","volume":"93","author":"Stoy","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib44","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2004.01.010","article-title":"Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system","volume":"16","author":"Tomas-Camardiel","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1471-4159.2005.03357.x","article-title":"Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease","volume":"95","author":"Van Raamsdonk","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib47","doi-asserted-by":"crossref","first-page":"10483","DOI":"10.1073\/pnas.1832501100","article-title":"Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington\u2019s disease","volume":"100","author":"Wang","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib48","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1523\/JNEUROSCI.21-10-03322.2001","article-title":"Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity","volume":"21","author":"Wang","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib49","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","article-title":"Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease","volume":"22","author":"Wu","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib50","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib51","doi-asserted-by":"crossref","first-page":"13496","DOI":"10.1073\/pnas.96.23.13496","article-title":"A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window","volume":"96","author":"Yrjanheikki","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib52","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington\u2019s disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ana.10476","article-title":"Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS","volume":"53","author":"Zhang","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2006.05.043_bib54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","article-title":"Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice","volume":"417","author":"Zhu","year":"2002","journal-title":"Nature"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452206007342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452206007342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T23:02:45Z","timestamp":1683500565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452206007342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"alternative-id":["S0306452206007342"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2006.05.043","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}